Deadline: 27-Dec-24 The Pfizer Research Grant aims to support preclinical research in hemophilia that investigate strategies to evaluate hemostatic potential of anti-TFPI therapies. Funding Information Individual projects requesting up to $50,000 USD will be considered. Pfizer anticipates awarding 2-4 projects in total. Duration Anticipated project length is 12 months. Geographic Scope US, Europe, Japan, China,… [Read More]
The post Monitoring of Anti-TFPI Therapies in Hemophilia Research Grant Program first appeared on fundsforNGOs.
Source: www2.fundsforngos.org…
